Liposomal formulation of a gold(III) metalloantibiotic: a promising strategy against antimicrobial resistance

A novel lipoformulation was developed by encapsulating cationic (S^C)-cyclometallated gold(III) complex [Au(dppta)(N Py-PZ-dtc)] (AuPyPZ) in liposomes. The liposomal form of compound AuPyPZ has a bactericidal action similar to that of the free drug without any appreciable effect on the viability of...

Full description

Saved in:
Bibliographic Details
Published in:Dalton transactions : an international journal of inorganic chemistry Vol. 53; no. 36; p. 15205
Main Authors: Llamedo, Alejandro, Rodríguez, Pablo, Gabasa, Yaiza, Soengas, Raquel G, Rodríguez-Solla, Humberto, Elorriaga, David, García-Alonso, Francisco J, Soto, Sara M
Format: Journal Article
Language:English
Published: England 18-09-2024
Subjects:
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A novel lipoformulation was developed by encapsulating cationic (S^C)-cyclometallated gold(III) complex [Au(dppta)(N Py-PZ-dtc)] (AuPyPZ) in liposomes. The liposomal form of compound AuPyPZ has a bactericidal action similar to that of the free drug without any appreciable effect on the viability of mammalian cells. Furthermore, the nanoformulation reduces metalloantibiotic-induced inhibition of hERG and the inhibition of cytochromes, significantly decreasing the potential liabilities of the metallodrug. The obtained metalloantibiotic liposomal formulation shows high stability and suitable properties for drug delivery, representing an effective strategy to fight against drug-resistant bacteria.
ISSN:1477-9234
DOI:10.1039/d4dt01867b